Suggested Event FIMEAn estimated two per cent of the global population are immunocompromised, meaning they have weakened immune systems that leave them at heightened risk of infection from bacteria and viruses, according to a report by Astrazeneca on immunocompromised patients. The Forgotten Millions: “Mapping Immunocompromised Patients in the Middle East and North Africa” report highlights the needs of this high-risk population and argues that protecting this group is critical. It further showcases the scale and experience of immunocompromised patients in the Middle East and North Africa (MENA) and recommends measures to better protect high-risk patients in the future. According to Prof. Al-Shamsi, cancer and diabetes represent up to one-third of the current overall disease burden in the MENA region. “Research studies specific to this region is critical as there is currently a lack of comprehensive data and understanding on immunocompromised individuals in the MENA region, leaving millions of people across the region vulnerable and disrupting efforts to end the pandemic,” added the professor.

Source: The North Africa Journal May 01, 2023 11:50 UTC